{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T04:06:31Z","timestamp":1749873991519,"version":"3.41.0"},"reference-count":41,"publisher":"Sociedad Espanola de Patologia Digestiva (SEPD)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Esp Enferm Dig"],"published-print":{"date-parts":[[2016]]},"DOI":"10.17235\/reed.2016.4235\/2016","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T09:45:33Z","timestamp":1481622333000},"source":"Crossref","is-referenced-by-count":5,"title":["Influence of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with antiviral triple therapy"],"prefix":"10.17235","volume":"109","author":[{"given":"\u00c1ngela","family":"Puente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaqu\u00edn","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"L\u00f3pez Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Est\u00e9banez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Casafont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"F\u00e1brega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6910","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009482"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010494"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.03.051"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.04.035"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12656"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-7-200004040-00002"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33023"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.02.022"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Burroughs AK, Groszmann R, et al. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point? Gut 2002; 50:425\u0096427","DOI":"10.1136\/gut.50.3.425"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00743.x"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(03)00219-6"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.02.008"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.01.051"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.07.020"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.01.034"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Castera L, Foucher J, et al., Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations, Hepatology 51 (2010), 828\u0096835.","DOI":"10.1002\/hep.23425"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21665"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.10.001"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.05.035"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.10.027"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.04.019"},{"key":"ref22","unstructured":"22. M. Kondo, S.J. Miszputen, et al. The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels, Hepatogastroenterology 42 (1995), 542\u0096545."},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"23. J. Kropf, A.M. Gressner and W. Tittor, Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum, Clin Chem 37 (1991), 30\u009635.","DOI":"10.1093\/clinchem\/37.1.30"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26755"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.03.002"},{"key":"ref26","unstructured":"26. Garc\u00eda-Tsao G, Rodiguez-Perez F, BleiaT, et al. Treatment with interferon reduces portal pressure in patients with chronic hepatitis C. A randomized placebo trial. Gastroenterology 1996;10:A1193."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.144878"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit234"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-6-200809160-00006"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.10.013"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2805"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-7-200004040-00002"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. Ballet F, Chretien Y, Rey C, et al. Differential response of normal and cirrhotic liver to vasoactive agents. A study in the isolated perfused rat liver. J Pharmacol Exp Ther 1988;244:283\u00969.","DOI":"10.1016\/S0022-3565(25)24274-4"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00432.2007"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"35. Oertli B, Beck-Schimmer B, et al. Mechanisms of hyaluronan-induced up-regulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-kappa B and activating protein-1. J Immunol 1998;161: 3431-3437.","DOI":"10.4049\/jimmunol.161.7.3431"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(13)60067-7"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50038"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20632"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040319"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30167-7"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"41. Vergiol J , Foucher J, Castera Let al Changes of non-invasive markers and FibroScan values during HCV treatment. J Viral Hepat. 2009 Feb;16(2):132-40.","DOI":"10.1111\/j.1365-2893.2008.01055.x"}],"container-title":["Revista Espa\u00f1ola de Enfermedades Digestivas"],"original-title":[],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T14:45:57Z","timestamp":1749825957000},"score":1,"resource":{"primary":{"URL":"https:\/\/online.reed.es\/fichaArticulo.aspx?iarf=683765748232-413275194169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":41,"URL":"https:\/\/doi.org\/10.17235\/reed.2016.4235\/2016","relation":{},"ISSN":["1130-0108"],"issn-type":[{"type":"print","value":"1130-0108"}],"subject":[],"published":{"date-parts":[[2016]]}}}